Skip to content

Choice of antibiotic in babies at risk of sepsis but without symptoms

Oral versus Injectable Antibiotics in Asymptomatic Neonates Born to Mothers with Risk Factors for Sepsis: A Randomized Controlled Trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/04/008335
Enrollment
126
Registered
2017-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P369- Bacterial sepsis of newborn, unspecified Health Condition 2: null- Neonates of gestational age more than or equal to 34 weeks with birth weight above 1800 g who are asymptomatic at birth and can be fed orally.

Interventions

Intervention1: Inj. ampicillin plus amikacin: Inj. ampicillin will be administered at a dose of 100 mg/kg/day in two divided doses for 3 days. Inj. amikacin will be administered at a dose of 15 mg/kg/

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: include all the following: 1. Consecutively delivered neonates of gestational age 34 weeks and beyond 2. with maternal risk factors for sepsis 2. who are otherwise asymptomatic at birth 3. accepting cup feeds and/or breastfeeds Maternal risk factors for sepsis are defined as presence of one or more of the following: o Leaking per vagina >18 hours o Foul smelling liquor o Maternal intrapartum fever >37.5°C in the period from onset of labor to 1 hour after delivery. Exclusion criteria: 1. Perinatal asphyxia 2. Respiratory distress 3. Major congenital malformations

Exclusion criteria

Exclusion criteria: 1. Perinatal asphyxia 2. Meconium aspiration syndrome 3. Congenital infections (TORCH, syphilis and HIV) 4. Surgical conditions and major congenital anomalies

Design outcomes

Primary

MeasureTime frame
Development of clinical signs of sepsis not explained otherwise with or without a positive blood cultureTimepoint: 72 hours of age

Secondary

MeasureTime frame
1. Development of sepsis with or without a positive blood culture by 7 days of life 2. Feasibility 3. Adherence to study protocol 4. Adverse effects of drug therapy 5. Cost-effectiveness Timepoint: 72 hours and 7 days of life

Countries

India

Contacts

Public ContactAshok Kumar

Institute of Medical Sciences Banaras Hindu University

definitely_dubey@rediffmail.com7565852195

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026